Daily Stock Ratings & Price Targets

Daily stock ratings from over 8,000 Wall Street analysts

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Tycho Peterson Jefferies	GH Guardant Health	BUY$75	24.94% Upside
Tom White D.A. Davidson	EXPI eXp World Holdings	BUY$12	8.40% Upside
Chris O`Cull Stifel Nicolaus	SBUX Starbucks	BUY$105	25.91% Upside
Julien Dumoulin Smith Jefferies	IDA IdaCorp	BUY$144	10.97% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Ken Hoexter Bank of America Securities	UPS United Parcel	SELL$81	-3.25% Downside
Darrin Peller Wolfe Research	PAYX Paychex	SELL$140	9.20% Upside
Meta Marshall Morgan Stanley	CIEN Ciena	SELL$100	-29.54% Downside
Andrea Pistacchi Bank of America Securities	BF.B Brown-Forman B	SELL$28.5	5.17% Upside

Full List of Stock Ratings

(Sep 27, 2025)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $103	―	15.80%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $165	―	19.30%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $112	―	23.20%	Reiterated	2025-09-26
Peter Lawson Barclays	RVMD Revolution Medicines	BUY $72	―	-5.40%	Reiterated	2025-09-26	Barclays Sticks to Their Buy Rating for Revolution Medicines (RVMD)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $190	―	16.40%	Reiterated	2025-09-26
Paul Kearney Barclays	LEVI Levi Strauss & Co	BUY $24→$26	―	0.30%	Reiterated	2025-09-26	Levi Strauss & Co (LEVI) Gets a Buy from Barclays
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $138	―	16.40%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $715	―	15.90%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $267	―	16.40%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $164	―	16.40%	Reiterated	2025-09-26
Peter Lawson Barclays	TNGX Tango Therapeutics	BUY $13	―	-5.40%	Reiterated	2025-09-26	Barclays Sticks to Their Buy Rating for Tango Therapeutics (TNGX)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY	―	8.20%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	7.10%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY	―	7.70%	Reiterated	2025-09-26
David Hoang Deutsche Bank	SYRE Spyre Therapeutics	BUY $43	―	0.60%	Initiated	2025-09-26	Spyre Therapeutics initiated with a Buy at Deutsche Bank
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $86→$143	―	12.30%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $280→$300	―	34.60%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $77→$86	―	13.30%	Upgraded	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $582→$625	―	13.10%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $40	―	9.20%	Downgraded	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $480	―	4.90%	Initiated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $70	―	4.90%	Initiated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $30	―	5.00%	Initiated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $28	―	4.90%	Initiated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	14.20%	Downgraded	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	18.90%	Downgraded	2025-09-26
Lisa Walter RBC Capital	UTHR United Therapeutics	BUY $569	―	-6.70%	Initiated	2025-09-26	Analysts Offer Insights on Healthcare Companies: United Therapeutics (NASDAQ: UTHR) and Zai Lab (NASDAQ: ZLAB)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $16→$24	―	15.90%	Downgraded	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $22→$20	―	15.90%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $15→$19	―	15.90%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $15→$14	―	15.90%	Downgraded	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $6→$12	―	15.90%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $85→$100	―	14.10%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $435	―	8.90%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY	―	18.50%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $34→$35	―	17.90%	Upgraded	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $42→$44	―	14.70%	Upgraded	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $1,095	―	8.60%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $75	―	18.90%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $27.5	―	8.80%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $170→$180	―	6.70%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $250→$265	―	50.80%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY	―	4.00%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $130	―	0.40%	Downgraded	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $23	―	13.40%	Initiated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $80→$52	―	1.90%	Downgraded	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $781	―	4.60%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $363→$364	―	21.50%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY	―	8.90%	Reiterated	2025-09-26
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $423→$430	―	5.00%	Reiterated	2025-09-26

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing